Status:
TERMINATED
The Intracept Global Registry ( TIGR ) - Pilot Study
Lead Sponsor:
Relievant Medsystems, Inc.
Collaborating Sponsors:
M Squared Associates, Inc.
Conditions:
Low Back Pain
Eligibility:
All Genders
18+ years
Brief Summary
The Intracept Global Registry is a prospective, noninterventional, observational global post market independent data collection of the ongoing effectiveness, safety, and satisfaction outcomes for pati...
Detailed Description
Participants in the registry will have seven study visits over a period of five years (one prior to procedure and 6 post their procedure). Study visits will be conducted via telephone by a third-party...
Eligibility Criteria
Inclusion
- All patients scheduled for the Intracept procedure and whose treating physician is referring to the registry
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
July 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04449835
Start Date
July 31 2020
End Date
December 1 2022
Last Update
January 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84112